Chiroscience Group - Offer Acceptances/Extended
28 Luglio 1999 - 9:35AM
UK Regulatory
RNS No 1118d
CHIROSCIENCE GROUP PLC
27 July 1999
Not for release, publication or distribution in or into the United States,
Canada, Australia or Japan
Celltech plc ("Celltech")
Recommended Merger Offer
for
Chiroscience Group plc ("Chiroscience")
Level of Acceptances and Extension of Merger Offer
By 3.00 p.m. on 27 July 1999, valid acceptances of the Merger Offer had been
received in respect of 80,698,978 Chiroscience Shares, representing
approximately 71.22 per cent. of the issued ordinary share capital of
Chiroscience.
The Board of Celltech announces that the Merger Offer has been extended until
3.00 p.m. on Tuesday, 10 August 1999.
Neither Celltech nor any person deemed to be acting in concert with it held
any Chiroscience Shares on 14 June 1999, the date immediately prior to the
commencement of the Merger Offer Period. Neither Celltech nor any person
deemed to be acting in concert with it has acquired or agreed to acquire any
Chiroscience Shares during the Merger Offer Period.
Enquiries:
Celltech
Dr. Peter Fellner Tel : 01753 534 655
Chiroscience
Christine Soden Tel : 01223 428 602
Flemings
Simon Gorringe Tel : 0171 638 5858
Edward Roskill
Terms defined in the Merger Offer Document dated 6 July 1999 have the same
meaning in this press release.
Flemings, which is regulated in the UK by The Securities and Futures Authority
Limited, is acting for Celltech and no one else in connection with the Merger
Offer and will not be responsible to anyone other than Celltech for providing
the protections afforded to customers of Flemings or for providing advice in
relation to the Merger Offer.
This announcement has been approved by Flemings for the purposes of section 57
of the Financial Services Act 1986.
END
OFFAFLLFDLIDFAA
Grafico Azioni Amedeo Res (LSE:AMED)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Amedeo Res (LSE:AMED)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Amedeo Res (Borsa di Londra): 0 articoli recenti
Più Chiroscience Group Articoli Notizie